The great therapeutic potential of human embryonic stem (ES) cells (see Box) and the thorny ethical issues surrounding their use have prompted many governments to revisit existing regulations on embryo research (see Table on next page). Just in recent weeks, the Canadian government proposed regulatory guidelines that would allow the derivation and use of ES cells from human embryos but, unlike legislation that was passed earlier this year in the United Kingdom, would outlaw the creation of embryos for research purposes. Meanwhile, in the United States the National Institutes of Health (NIH) called off its review of research proposals that make use of ES cells -the first to be submitted since the moratorium on federally funded research in this area was lifted last year. The issue as to whether NIH should fund embryo research is currently under review by Health and Human Services Secretary Tommy Thompson.
The proposed Canadian law, submitted to a parliamentary committee by Liberal Health Minister Allan Rock, deals with all aspects of reproductive technology, including embryo research. It advocates that research on stem cells from human embryos that have been created by in vitro fertilization should be allowed under strict guidelines. However, all human cloning (regardless of whether it is for therapeutic or reproductive purposes) and the creation of embryos to obtain stem cells are banned. According to Janet Rossant, co-head of the program in development and fetal health at the Samuel Lunenfeld Research Institute in Toronto, Canada, the scientific community is supportive of the legislation because "we want to see research with human embryos move forward and to do that you need clear regulatory guidelines."
Rossant was chair of an ad hoc Working Group on Stem Cell Research formed at the request of the Canadian Institutes of Health Research (CIHR, a funding agency analogous to the NIH). The group's recommendations to allow CIHR funding of human ES cell research but not the creation of embryos for research purposes or the creation of human-animal chimeras were released for public comment on April 29 and will serve as the basis for CIHR to develop guidelines for funding stem cell research.
Although the proposed CIHR guidelines cover only publicly funded research, the CIHR urged the government to create a national body to oversee all stem cell research, so that private and public sector would abide to the same guidelines. The legislation to be introduced to Canadian parliament proposes to do just that. However, according to Rossant, how the
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As the US government ponders the fate of stem cell research, two recent reports by US scientists -one dealing with embryonic and the other with adult stem cells -provide evidence of the therapeutic potential of this research.
In one report published on Science's website on April 26 scientists coaxed mouse embryonic stem cells in a dish to form three-dimensional clusters that look and act like islets of Langerhans in the pancreas -the structures responsible for producing and secreting insulin in response to blood sugar levels. According to senior author Ron McKay of the National Institutes of Health, the differentiated cells produce insulin through the same mechanisms that are used in vivo. The work suggests that cells derived from human embryos could be transplanted into diabetic patients who lack functional pancreatic islets. What is even more exciting to McKay than the therapeutic potential of this work is that these cells assemble in the right architecture, mimicking what happens during organogenesis. "We have shown that stem cells are capable of self-assembly, " says McKay. The islets worked properly when transplanted into diabetic mice but they only produced 2% of the insulin, a level too low to normalize the animals' blood sugar levels. "What this tells us is that we have not done it all, " says McKay.
The second report, published in the May 4 issue of Cell, showed that a single bone-marrow derived stem cell is capable not only of reconstituting the bone marrow when transplanted to irradiated mice but also of developing into epithelial cells of multiple organs (including the intestines, lung, and skin). "We were greatly excited to find 20% differentiation in the lung tissue 11 months post transplant of individual adult hematopoietic stem cells, " says Saul Sharkis, author of the study and director of the experimental hematopoiesis program at Johns Hopkins Medical Institute. The results of the study also indicate that adult stem cells might be summoned to sites of injury to differentiate into multiple types of cells, suggesting that these stem cells might be able to repair damaged tissues throughout the body and serve as treatment for a variety of diseases characterized by tissue and organ damage. However, Sharkis cautions that "it is clearly too soon to predict any therapeutic application for these adult cells. " Sharkis also said that it is too early to draw any comparisons between the level of plasticity of adult versus embryonic stem cells.
The promise of stem cell research
regulatory body will function under the proposed legislation still needs to be worked out. One possibility is that "it might be like the HFEA [Human Fertilisation and Embryology Authority] in the United Kingdom," says Rossant.
The regulations proposed for Canadian scientists might end up being more liberal than those adopted in the United States, at least for federally funded researchers. At the moment the NIH cannot fund any embryo research.
After the Clinton administration lifted the moratorium on NIHfunded embryo research, the NIH laid out specific guidelines that were published in August 2000. The guidelines limited funding to the use of human ES cells taken from frozen spare embryos from fertility clinics and already destined to be discarded and obtained with the informed consent of the donating couples. But, unlike the proposed regulations in Canada, US federal funds could not be used to destroy the embryos to obtain the cells. In other words, privately funded researchers would have to pass them on to federally supported scientists.
All NIH-funded research proposing to use human pluripotent stem cells was to undergo the regular scientific peer-review as well as a formal review of documentation of compliance with the NIH guidelines by the Human Pluripotent Stem Cell Review Group (HPSCRG).
The decision to call off the first meeting of the HPSCRG and to review current guidelines has left many US scientists concerned that they will be cut off from an important area of research. Another concern is that if NIH does not fund this type of research, funding will be left to private organizations and individuals, which, in the absence of legislation, are largely unregulated.
A new coalition including the American Society for Cell Biology, the Juvenile Diabetes Foundation, and Harvard University, which calls itself the Coalition for the Advancement of Medical Research was established in March to put pressure on the government to support ES cell research. In addition, earlier this year 80 Nobel laureates sent a letter to President Bush indicating that "it is premature to conclude that adult stem cells have the same potential as embryonic stem cells" and that research on both fronts should be continued.
Meanwhile, in April Republicans introduced to US Congress two separate bills that would ban somatic cell nuclear transfer using human cells (human cloning) regardless of whether the technique is used in research or reproduction. The ban would affect both publicly and privately funded research.
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